[1]兰福全,李秀云,卢 斌.四种肿瘤标志物对肝癌诊断的临床意义[J].医学信息,2018,31(21):164-166.[doi:10.3969/j.issn.1006-1959.2018.21.048]
　LAN Fu-quan,LI Xiu-yun,LU Bin.The Clinical Significance of Four Tumor Markers in the Diagnosis of Liver Cancer[J].Journal of Medical Information,2018,31(21):164-166.[doi:10.3969/j.issn.1006-1959.2018.21.048]
点击复制

四种肿瘤标志物对肝癌诊断的临床意义()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年21期
页码:
164-166
栏目:
诊疗技术
出版日期:
2018-11-01

文章信息/Info

Title:
The Clinical Significance of Four Tumor Markers in the Diagnosis of Liver Cancer
文章编号:
1006-1959（2018）21-0164-03
作者:
兰福全1; 李秀云1; 卢 斌2
北京四季青医院内科1，检验科2，北京 100097
Author(s):
LAN Fu-quan1; LI Xiu-yun1; LU Bin2
Department of Internal Medicine1,Department of Clinical Laboratory2,Beijing Sijiqing Hospital,Beijing 100097,China
关键词:
肝癌; 肿瘤标志物; 敏感性
Keywords:
Liver cancer; Tumor markers; Sensitivity
分类号:
R735.7
DOI:
10.3969/j.issn.1006-1959.2018.21.048
文献标志码:
A
摘要:
目的 通过联合检测肿瘤标志物CEA、CA125、AFP、CA199在肝癌患者血清中的水平，探讨其在肝癌诊断中的价值。方法 选取2016年1月~2018年4月我院收治的75例原发性肝癌患者作为肝癌组，选取同期于我院就诊的脂肪肝、乙型肝炎、肝硬化、肝囊肿患者60例作为肝良性病变组，从同期健康体检者中选取60名作为健康对照组。检测肿瘤标志物CEA、CA125、AFP、CA199水平，对比各组肿瘤标志物检测水平以及四项肿瘤标志物对肝癌单检及联检的敏感性和特异性。结果 肝癌组CEA、CA125、AFP、CA199血清水平均高于肝良性病变组和健康对照组，差异具有统计学意义（P＜0.05）；四种肿瘤标记物的测定数值，肝癌组最高，肝良性病变组次之，健康对照组最低。肝癌组中血清AFP单项检测的敏感性、特异性均高于CEA、CA125和CA199的检测，但四种肿瘤标记物联合检测的敏感性高于每一个单项的敏感性，差异具有统计学意义（P＜0.05）；四项联合检测的特异性并未出现升高。结论 CEA、CA125、AFP、CA199四种肿瘤标记物对肝癌均有一定诊断价值，联合检测可大大提高灵敏度，对肝癌的早期诊断和鉴别具有重要意义。
Abstract:
Objective To explore the value of the joint detection of serum CEA, CA125, AFP and CA199 to the diagnosis of liver cancer. Methods 75 patients with primary liver cancer admitted to our hospital from January 2016 to April 2018 were selected as the liver cancer group. 60 patients with fatty liver, hepatitis B, cirrhosis and hepatic cysts who were treated in our hospital at the same time were selected as liver benign in the lesion group, 60 healthy subjects were selected as healthy controls from the same period. levels of tumor markers CEA, CA125, AFP and CA199 were detected by Roche cobas e601 electrochemiluminescence method. The detection levels of tumor markers in each group were compared. Sensitivity and specificity of tumor markers for single and joint detection of liver cancer.Results The serum levels of CEA, CA125, AFP and CA199 in liver cancer group were higher than those in benign liver disease group and healthy control group, the difference was statistically significant (P<0.05). The value of four tumor markers was the highest in liver cancer group and benign in liver. The lesion group was the second, and the healthy control group was the lowest. The sensitivity and specificity of serum AFP single detection in liver cancer group were higher than those of CEA, CA125 and CA199, but the sensitivity of combined detection of four tumor markers was higher than that of each single item, and the difference was statistically significant (P<0.05); the specificity of the four co-tests did not increase.Conclusion The four tumor markers CEA, CA125, AFP and CA199 have certain diagnostic value for liver cancer. Combined detection can greatly improve the sensitivity and is of great significance for the early diagnosis and identification of liver cancer.

参考文献/References:

[1]张天明,王玉平,周永宁.肝癌肿瘤标记物的研究进展[J].胃肠病学和肝病学杂志,2016,25(8):852-856. [2]崔灿,牛国平.肿瘤标志物联合检测对原发性肝癌的诊断价值[J].现代肿瘤医学,2015,23(9):1262-1265. [3]郑飞,周文平.四种肿瘤标记物联合检测诊断原发性肝癌的临床观察[J].中国肿瘤临床与康复,2013,20(9):941-943. [4]中华人民共和国国家卫生和计划生育委员.原发性肝癌诊疗规范(2017年版)[J].临床肝胆病杂志,2017,33(8):1419-1431. [5]Li S,Yang F,Ren X.Immunotherapy for hepatocellular carcinoma[J].Drug Discov Ther,2015,9(5):363-371. [6]康从利,王艳,林雪,等.血清肿瘤标记物联合检测诊断原发性肝癌的临床应用研究[J].中华临床医师杂志,2014,8(13):2408-2411. [7]王梅,孟华,刘晓颖.AFP、CEA、CA199、CA724联合检测在消化道恶性肿瘤中的临床价值[J].胃肠病学和肝病学杂志,2011,20(6):546-548. [8]方宗信,李秀义,黄瑞茹,等.肿瘤标记物联合检测对原发性肝癌的临床诊断价值探讨[J].检验医学与临床,2013,10(8):942-943.

相似文献/References:

[1]修朋程,李 腾,李雅林,等.泰山山慈菇对小鼠肝癌的治疗作用及相关免疫机制研究[J].医学信息,2018,31(09):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
　XIU Peng-cheng,LI Teng,LI Ya-lin,et al.Study on the Therapeutic Effect and Mechanism of Taishan Mountain Mushroom on Liver Cancer in Mice[J].Journal of Medical Information,2018,31(21):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
[2]崔康健,杜成友.肝动脉化疗栓塞联合射频消融治疗肝癌的研究进展[J].医学信息,2018,31(09):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
　CUI Kang-jian,DU Cheng-you.Research Progress of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation for Liver Cancer[J].Journal of Medical Information,2018,31(21):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
[3]田 明,常伟平.UbcH10在肝癌中的表达及其与预后的关系[J].医学信息,2019,32(12):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
　IAN Ming,CHANG Wei-ping.Expression of UbcH10 in Hepatocellular Carcinoma and Its Relationship with Prognosis[J].Journal of Medical Information,2019,32(21):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
[4]钟 磊,谢海燕,林 霖.电化学发光免疫分析技术检测肿瘤标志物在乳腺癌诊断中的应用[J].医学信息,2018,31(20):155.[doi:10.3969/j.issn.1006-1959.2018.20.048]
　ZHONG Lei,XIE Hai-yan,LIN Lin.Application of Electrochemiluminescence Immunoassay for Detection of Tumor Markers in Diagnosis of Breast Cancer[J].Journal of Medical Information,2018,31(21):155.[doi:10.3969/j.issn.1006-1959.2018.20.048]
[5]许 吉.基于知识图谱和专利地图的我国抗肝癌药物研发态势研究[J].医学信息,2018,31(21):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
　XU Ji.Research and Development Situation of Anti-liver Cancer Drugs in China Based on Knowledge Map and Patent Map[J].Journal of Medical Information,2018,31(21):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
[6]魏优蕾,郭晓彤.肺癌患者血浆检测肿瘤标志物的分析方法及展望[J].医学信息,2019,32(07):39.[doi:10.3969/j.issn.1006-1959.2019.07.014]
　WEI You-lei,GUO Xiao-Tong.Analytical Methods and Prospects of Plasma Detection of Tumor Markers in Patients with Lung Cancer[J].Journal of Medical Information,2019,32(21):39.[doi:10.3969/j.issn.1006-1959.2019.07.014]
[7]杨寿林,宋庆志,吴路发,等.肿瘤标志物和凝血指标在肺癌辅助诊断中的效果分析[J].医学信息,2019,32(07):168.[doi:10.3969/j.issn.1006-1959.2019.07.053]
　YANG Shou-lin,SONG Qing-zhi,WU Lu-fa,et al.Efficacy Analysis of Tumor Markers and Coagulation Parameters in the Diagnosis of Lung Cancer[J].Journal of Medical Information,2019,32(21):168.[doi:10.3969/j.issn.1006-1959.2019.07.053]
[8]李 闯,叶劲松,刘 昕,等.ZBP-89与缺氧信号因子HIF-1α在肝癌细胞中的 相关性研究[J].医学信息,2019,32(15):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
　LI Chuang,YE Jin-song,LIU Xin,et al.Correlation between ZBP-89 and Hypoxia Signaling Factor HIF-1α in Hepatoma Cells[J].Journal of Medical Information,2019,32(21):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
[9]赵瑶瑶,高 川,胡佳杰.循环miRNA监测肝细癌的研究[J].医学信息,2019,32(08):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
　ZHAO Yao-yao,GAO Chuan,HU Jia-jie.Research on the Study of Circulating miRNA for Monitoring Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(21):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
[10]张东霞.腹腔镜下卵巢子宫内膜样囊肿剥除术对患者肿瘤标志物及卵巢储备功能的影响[J].医学信息,2022,35(13):116.[doi:10.3969/j.issn.1006-1959.2022.13.026]
　ZHANG Dong-xia.Effect of Laparoscopic Ovarian Endometrioid Cystectomy on Tumor Markers and Ovarian Reserve Function[J].Journal of Medical Information,2022,35(21):116.[doi:10.3969/j.issn.1006-1959.2022.13.026]
[11]刘瀚予,贾莉莉,喻文立,等.外泌体在肝癌中的作用机制研究进展[J].医学信息,2020,33(08):26.[doi:10.3969/j.issn.1006-1959.2020.08.010]
　LIU Han-yu,JIA Li-li,YU Wen-li,et al.The Mechanism of Exosomes in Liver Cancer[J].Journal of Medical Information,2020,33(21):26.[doi:10.3969/j.issn.1006-1959.2020.08.010]

更新日期/Last Update: 2018-11-20